Document is current
Any future updates will be listed below
-
Authors
Kimura, Noriyuki
Sasaki, Kotaro
Masuda, Teruaki
Ataka, Takuya
Matsumoto, Mariko
Kitamura, Mika
Nakamura, Yosuke
Matsubara, Etsuro
- License Information
-
More Information
Article History
Received: 26 September 2024
Accepted: 17 December 2024
First Online: 21 January 2025
Declarations
:
: The study protocol was approved by the local ethics committee of Oita University Hospital. Given the difficulty of obtaining informed consent for existing patient information, an information disclosure document (approved by the ethics committee and authorized by the head of Oita University Hospital) that included information on the conduct of this study and the study purpose was made publicly available on the university website. The study was registered with the University hospital Medical Information Network Clinical Trials Registry (UMIN000051776).
: Not applicable.
: NK has received consultancy/speaker fees from Takeda Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Sumitomo Pharma Co., Ltd., PDRadiopharma Inc., Otsuka Pharmaceutical Co., Ltd., and Eli Lilly Japan K.K. KS, MM, MK and YN are employees of Eisai Co., Ltd. TM, TA, and EM have no competing interest to declare.
